ADM Reports Third Quarter 2026 Results

ADM reported 3Q26 net earnings of $821 million and adjusted net earnings of $858 million; EPS was $1.70, with adjusted EPS of $1.77. The company raised its 2026 adjusted EPS outlook to approximately $5.50–$5.80 from $5.15–$5.60.

Analysis

The guidance increase improves near-term earnings visibility, but without segment results or the drivers behind the revision, it does not yet establish a durable improvement in ADM’s earnings power. For an agricultural processor, the key distinction is whether upside comes from repeatable operating performance or from volatile crush/origination margins, timing, and other items that may reverse. The latter could lift the current outlook while leaving medium-term estimates and the valuation multiple unchanged.

Over the next few sessions, the main risk is an overly positive read-through before investors can assess segment operating profit, cash conversion, and working-capital movements. Over 1–3 months, those disclosures—and subsequent commentary on crop availability, processing margins, and biofuel-policy exposure—should determine whether estimates move beyond the raised range. Over 6–18 months, sustained earnings quality would matter more than this single revision; otherwise, ADM remains exposed to commodity-cycle volatility and potential margin competition from peers such as Bunge Global.

The contrarian opportunity is to avoid treating a higher annual EPS range as proof of a structural turn. The thesis is falsified positively if segment profits and cash generation corroborate the outlook and management sustains or raises guidance; it is weakened by a reversal in operating trends, poor cash conversion, or a subsequent guidance cut. The supplied article excerpt omits the detailed results and rationale, so conviction should remain limited until verified.

Key Decisions for Investors

• Do not chase the headline alone. Treat ADM as a conditional, modest long on post-report weakness only after reviewing segment operating profit, adjusted-to-reported earnings reconciliation, and operating cash flow.
• For a 1–3 month catalyst, monitor the next management commentary and estimate revisions for evidence that the higher outlook reflects repeatable segment performance rather than temporary margin or timing effects.
• Keep exposure sized for cyclical reversal: reassess promptly if segment performance deteriorates or management reduces the outlook. No price-based stop or target is supportable from the supplied information.
• Before taking a relative-value position versus Bunge Global or other processors, verify comparable segment trends and valuation; the excerpt alone does not establish that ADM is outperforming peers.